PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.16%
Net income growth 1.25-1.5x TSM's 11.13%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-2.08%
Both reduce yoy D&A, with TSM at -0.49%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-29.17%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.23%
SBC growth of 9.23% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
66.08%
Less working capital growth vs. TSM's 193.43%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
103.68%
AR growth well above TSM's 46.85%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
27.39%
Inventory shrinking or stable vs. TSM's 99.86%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-139.08%
Both negative yoy AP, with TSM at -60.75%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
132.91%
Lower 'other working capital' growth vs. TSM's 441.51%. David Dodd would see fewer unexpected short-term demands on cash.
-73.47%
Negative yoy while TSM is 82.59%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
57.42%
Operating cash flow growth at 75-90% of TSM's 74.79%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-34.21%
Negative yoy CapEx while TSM is 0.97%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-6.12%
Both yoy lines negative, with TSM at -79.38%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
3.68%
Below 50% of TSM's 168.59%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-300.00%
Both yoy lines negative, with TSM at -3.93%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-14.07%
We reduce yoy invests while TSM stands at 3.98%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
49.21%
Debt repayment well below TSM's 99.05%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
No Data
No Data available this quarter, please select a different quarter.
-624.14%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.